EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Radiofrequency ablation: mechanisms and clinical applications

Jianhua Wu, Zhiyuan Zhou, Yuanwen Huang, Xinyue Deng, Siting Zheng, Shangwen He, Genjie Huang, Binghui Hu, Min Shi, Wangjun Liao, Na Huang

MedComm · 2024-10 · 5 (10)

DOI: 10.1002/mco2.746 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 02.10.2024. Verfasst von Jianhua Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Nanfang Hospital Southern Medical University Guangzhou Guangdong China. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 285 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Southern Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiofrequency ablation (RFA), a form of thermal ablation, employs localized heat to induce protein denaturation in tissue cells, resulting in cell death. It has emerged as a viable treatment option for patients who are ineligible for surgery in various diseases, particularly liver cancer and other tumor‐related conditions. In addition to directly eliminating tumor cells, RFA also induces alterations in the infiltrating cells within the tumor microenvironment (TME), which can significantly impact treatment outcomes. Moreover, incomplete RFA (iRFA) may lead to tumor recurrence and metastasis. The current challenge is to enhance the efficacy of RFA by elucidating its underlying mechanisms. This review discusses the clinical applications of RFA in treating various diseases and the mechanisms that contribute to the survival and invasion of tumor cells following iRFA, including the roles of heat shock proteins, hypoxia, and autophagy. Additionally, we analyze‌ the changes occurring in infiltrating cells within the TME after iRFA. Finally, we provide a comprehensive summary of clinical trials involving RFA in conjunction with other treatment modalities in the field of cancer therapy, aiming to offer novel insights and references for improving the effectiveness of RFA.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancer liver metastasescombination therapieshepatocellular carcinomaincomplete radiofrequency ablationtumor microenvironment

Autor:innen und Institutionen

  • Department of Oncology, Nanfang Hospital Southern Medical University Guangzhou Guangdong China.
  • Department of Respiratory and Critical Care Medicine Chronic Airways Diseases Laboratory, Nanfang Hospital, Southern Medical University Guangzhou Guangdong China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Southern Medical University

Zitieren

APA

Wu, J., Zhou, Z., Huang, Y., Deng, X., Zheng, S., He, S., Huang, G., Hu, B., Shi, M., Liao, W., & Huang, N. (2024). Radiofrequency ablation: mechanisms and clinical applications. MedComm, 5(10). https://doi.org/10.1002/mco2.746

Vancouver

Wu J, Zhou Z, Huang Y, Deng X, Zheng S, He S, et al. Radiofrequency ablation: mechanisms and clinical applications. MedComm. 2024;5(10). doi:10.1002/mco2.746

BibTeX
@article{Wu2024,
  author = {Wu, Jianhua and Zhou, Zhiyuan and Huang, Yuanwen and Deng, Xinyue and Zheng, Siting and He, Shangwen and Huang, Genjie and Hu, Binghui and Shi, Min and Liao, Wangjun and Huang, Na},
  title = {Radiofrequency ablation: mechanisms and clinical applications},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {10},
  doi = {10.1002/mco2.746}
}
Kostenlos starten →